Overview

Isoquercetin in Sickle Cell Anemia

Status:
Withdrawn
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This research study is being done to assess the safety and effectiveness of isoquercetin to reduce levels of soluble P-Selectin in patients with sickle cell disease. Isoquercetin is a naturally occurring flavonoid-or vitamin. You will find quercetin and isoquercetin in fruits and vegetables. The names of the study drug involved in this study are/is: - Isoquercetin
Phase:
Phase 2
Details
Lead Sponsor:
Jeffrey Zwicker, MD
Collaborator:
Quercegen Pharmaceuticals